av/cyclo-therapeutics--big.svg

NASDAQ:CYTHW

Cyclo Therapeutics

  • Stock

USD

Last Close

0.72

26/03 20:00

Market Cap

39.49M

Beta: -

Volume Today

186.81K

Avg: 2.95K

PE Ratio

−1.53

PFCF: −2.83

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.57M
-
950.46K
39.36%
1.50M
58.13%
1.24M
17.64%
1.01M
18.28%
1.01M
0.42%
903.38K
10.31%
1.59M
75.54%
1.38M
13.24%
1.08M
21.76%
cost of revenue
272.64K
-
124.42K
54.36%
198.43K
59.48%
132.92K
33.01%
105.03K
20.98%
75.49K
28.12%
66.40K
12.05%
156.08K
135.07%
138.93K
10.99%
3.49M
2,409.61%
gross profit
1.29M
-
826.03K
36.20%
1.30M
57.92%
1.10M
15.30%
906.45K
17.96%
931.71K
2.79%
836.98K
10.17%
1.43M
70.81%
1.24M
13.49%
-2.41M
294.87%
selling and marketing expenses
10.90K
-
7.57K
30.55%
7.16K
5.42%
7.85K
9.61%
5.64K
28.09%
5.88K
4.29%
5.01K
14.94%
18.34K
266.28%
13.06K
28.77%
3.90K
70.12%
general and administrative expenses
1.53M
-
2.22M
44.89%
2.64M
18.91%
2.62M
0.71%
2.43M
7.42%
3.43M
41.28%
3.68M
7.06%
6.50M
76.79%
7.81M
20.12%
5.66M
27.46%
selling general and administrative expenses
1.55M
-
2.23M
44.36%
2.65M
18.83%
2.63M
0.69%
2.44M
7.48%
3.44M
41.20%
3.68M
7.02%
6.52M
77.04%
7.82M
19.98%
3.46M
55.77%
research and development expenses
94.13K
-
658.50K
599.55%
1.86M
183.18%
2.29M
22.96%
2.71M
18.25%
4.87M
79.59%
6.10M
25.21%
9.15M
50.15%
9.00M
1.68%
14.18M
57.58%
other expenses
217.52K
-
202.01K
7.13%
130.95K
35.18%
19.77K
84.90%
13.95K
29.47%
13.98K
0.22%
19.95K
42.75%
27.54K
38.01%
30.50K
10.77%
cost and expenses
2.13M
-
3.22M
51.00%
4.85M
50.66%
5.08M
4.81%
5.27M
3.70%
8.40M
59.47%
9.86M
17.45%
15.85M
60.73%
16.99M
7.15%
21.13M
24.37%
operating expenses
1.86M
-
3.09M
66.47%
4.65M
50.31%
4.95M
6.43%
5.16M
4.36%
8.32M
61.25%
9.80M
17.72%
15.70M
60.23%
16.85M
7.33%
17.64M
4.70%
interest expense
33.67K
-
31.29K
7.08%
28.60K
8.59%
-150.45K
-
ebitda
-409.87K
-
-2.10M
411.49%
-3.24M
54.32%
-3.83M
18.43%
-4.24M
10.77%
-7.24M
70.67%
-8.97M
23.78%
-14.23M
58.74%
-15.75M
10.68%
-20.03M
27.16%
operating income
-562.31K
-
-2.41M
328.01%
-4.21M
74.75%
-3.84M
8.62%
-4.27M
11.02%
-7.39M
73.22%
-8.96M
21.23%
-14.27M
59.24%
-15.61M
9.42%
-20.05M
28.43%
depreciation and amortization
152.45K
-
169.03K
10.88%
107.10K
36.64%
9.27K
91.34%
10.12K
9.20%
147.43K
1,356.20%
-5.77K
103.91%
35.35K
712.95%
-141.25K
499.57%
19.28K
113.65%
total other income expenses net
3.30K
-
-134.63K
4,179.70%
-853.02K
533.60%
7.58K
100.89%
-377
104.97%
-141.75K
37,498.14%
18.53K
113.07%
-18.52K
199.96%
160.73K
967.76%
-7.24K
104.51%
income before tax
-592.69K
-
-2.43M
310.23%
-4.22M
73.72%
-3.83M
9.25%
-4.26M
11.01%
-7.53M
77.03%
-8.94M
18.71%
-14.29M
59.78%
-15.45M
8.15%
-20.06M
29.81%
income tax expense
33.67K
-
120K
256.37%
28.60K
76.16%
11.77K
-
141.75K
1,103.98%
-18.53K
113.07%
18.52K
199.96%
-171.00K
1,023.22%
4
100.00%
net income
-592.69K
-
-2.55M
330.48%
-4.22M
65.55%
-3.83M
9.25%
-4.26M
11.01%
-7.67M
80.36%
-8.92M
16.27%
-14.31M
60.32%
-15.28M
6.81%
-20.06M
31.27%
weighted average shs out
505.43K
-
562.09K
11.21%
633.54K
12.71%
720.37K
13.70%
817.57K
13.49%
1.22M
48.69%
1.60M
31.55%
6.37M
298.32%
6.37M
0.03%
16.33M
156.43%
weighted average shs out dil
505.43K
-
562.09K
11.21%
633.54K
12.71%
720.37K
13.70%
817.57K
13.49%
1.22M
48.69%
1.60M
31.55%
6.37M
298.32%
6.37M
0.03%
16.33M
156.43%
eps
-1.17
-
-4.54
288.03%
-6.67
46.92%
-5.32
20.24%
-5.20
2.26%
-6.31
21.35%
-5.58
11.57%
-2.25
59.68%
-2.40
6.67%
-1.23
48.75%
epsdiluted
-1.17
-
-4.54
288.03%
-6.67
46.92%
-5.32
20.24%
-5.20
2.26%
-6.31
21.35%
-5.58
11.57%
-2.25
59.68%
-2.40
6.67%
-1.23
48.75%

All numbers in USD (except ratios and percentages)